| CAS ID: | 62571-86-2 |
| Molecular Formula: | C9H15NO3S |
| Molecular Weight: | 217.3 g/mol |
| Monoisotopic Mass: | 217.0773 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | CAPTOPRIL | CAPTOMEX | SQ 14,225 | HYTENEZE 25 | CAPOTEN | NOYADA | ACEPRIL | Lopril | HYTENEZE 12.5 | KAPLON | ECOPACE | HYTENEZE 50 | Tensobon |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
Reference Record 2
| PubMed ID | 20881240 | Target ID | |
| Uniprot ID | Name | ||
| Model | mice | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT00077064 | Disease | Pulmonary fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | February 11, 2004 | Last Verified | March 8, 2018 |
| Sponsor | Radiation Therapy Oncology Group | ||
| PubChem: | 44093 |
| ChEMBL: | CHEMBL1560 |